These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 22361928

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Antioxidant and anti-inflammatory efficacy of NAC in the treatment of COPD: discordant in vitro and in vivo dose-effects: a review.
    Sadowska AM, Manuel-Y-Keenoy B, De Backer WA.
    Pulm Pharmacol Ther; 2007; 20(1):9-22. PubMed ID: 16458553
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of laxative and N-acetylcysteine on mucus accumulation, bacterial load, transit, and inflammation in the cystic fibrosis mouse small intestine.
    De Lisle RC, Roach E, Jansson K.
    Am J Physiol Gastrointest Liver Physiol; 2007 Sep; 293(3):G577-84. PubMed ID: 17615175
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. New developments in the treatment of COPD: comparing the effects of inhaled corticosteroids and N-acetylcysteine.
    van Overveld FJ, Demkow U, Górecka D, de Backer WA, Zielinski J.
    J Physiol Pharmacol; 2005 Sep; 56 Suppl 4():135-42. PubMed ID: 16204787
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Use of thiols and implications for the use of inhaled corticosteroids in the presence of oxidative stress in COPD.
    Cazzola M, Page CP, Wedzicha JA, Celli BR, Anzueto A, Matera MG.
    Respir Res; 2023 Jul 31; 24(1):194. PubMed ID: 37517999
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Multifaceted activity of N-acetyl-l-cysteine in chronic obstructive pulmonary disease.
    Calzetta L, Matera MG, Rogliani P, Cazzola M.
    Expert Rev Respir Med; 2018 Aug 31; 12(8):693-708. PubMed ID: 29972340
    [Abstract] [Full Text] [Related]

  • 16. N-acetyl-L-cysteine (NAC) inhibit mucin synthesis and pro-inflammatory mediators in alveolar type II epithelial cells infected with influenza virus A and B and with respiratory syncytial virus (RSV).
    Mata M, Morcillo E, Gimeno C, Cortijo J.
    Biochem Pharmacol; 2011 Sep 01; 82(5):548-55. PubMed ID: 21635874
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. N-acetylcysteine counteracts oxidative stress and prevents hCG-induced apoptosis in rat Leydig cells through down regulation of caspase-8 and JNK.
    Aggarwal A, Misro MM, Maheshwari A, Sehgal N, Nandan D.
    Mol Reprod Dev; 2010 Oct 01; 77(10):900-9. PubMed ID: 20824644
    [Abstract] [Full Text] [Related]

  • 20. [Acetylcysteine in the treatment of severe COPD].
    Dekhuijzen PN.
    Ned Tijdschr Geneeskd; 2006 Jun 03; 150(22):1222-6. PubMed ID: 16796172
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.